Search results

Demonstrates _Freq51_ and _Specgrm2_, two analysis programs from the Biomedical Ultrasonics Laboratory at the University of Michigan, available for DOS or Linux. The _Spectrum Analyser (Freq51)_ provides power spectrum levels as a function of frequency, configurable for absolute values (e.g., dB re 1 volt) with sound card calibration. _Spectrogram (Specgrm2)_ generates a real-time, full-screen spectrogram (sonagram) with various color options. These programs analyze incoming signals in real time, not stored files, and offer extensive settings for sampling rate, FFT points, and averaging time, making them highly versatile for acoustic analysis. The DOS version of _Freq51_ and _Specgrm2_ can operate under Windows 95, requiring users to configure sound card switches via a text file. The resource also briefly mentions other acoustic analysis software like Gianni Pavan's DOS-based bioacoustic tools, _Gram_ by R.S. Horne for Windows, _SASLab_ (Light and Pro versions), _Cool Edit_, and _GoldWave_, providing a comparative overview of available tools for real-time and file-based spectral analysis and waveform manipulation.

The Dilawri Cardiovascular Institute (DCI) is a prominent Canadian organization dedicated to advancing cardiovascular health through cutting-edge research, equitable patient care, and medical innovation. It integrates 16 core centers, including specialized units like the Centre for AI, Data Science, and Imaging, and the Centre for Heart Rhythm, to bridge research findings directly into clinical practice. Their mission emphasizes providing world-class cardiac care accessible to all patients, regardless of their geographic location, by employing disruptive innovation and creative strategies to reach individuals faster. The institute focuses on a team-based approach, ensuring patients receive the correct therapy at the optimal time for long-term well-being. DCI's commitment extends to continuous growth through education, pushing boundaries beyond standard care, and fostering a respectful, inclusive environment for both staff and patients. They lead industry collaborations to shape the detection, treatment, and management of heart disease.